Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Harrow, Inc. is a pharmaceutical company specializing in ophthalmic products, including FDA-approved branded drugs and compounded medications. It serves U.S. eye care professionals with a broad portfolio of prescription and non-prescription treatments for conditions like dry eye, infections, inflammation, and surgical needs. The company owns ImprimisRx, a leading ophthalmology-focused compounding business, and leverages proprietary formulations, patents, and strategic licensing to provide accessible, affordable eye care solutions.
This description was generated via AI from an annual report. Updated about 1 year ago.